author-placeholder

Dr David Irving

Director of Research and Development, The Australian Red Cross Blood Service
Background and research interests : With formal training in biochemistry, cell and molecular biology and management, David has over 25 years’ experience in the biomedical and life sciences. His early research interests were focussed in the field of molecular approaches to parasite vaccine development, in particular malaria vaccine development. He held postdoctoral positions at the Rockefeller University, New York, and CSIRO, Sydney and has an MSc and PhD from the Australian National University and a Graduate Certificate of Management (Technology Management) from Deakin University. He is also a Graduate of the Australian Institute of Company Directors. David was the inaugural CEO of the Diabetes Vaccine Development Centre (DVDC) and held executive management positions with Biotech Australia Pty Limited, Sydney and its successor companies.

More from this expert

Upcoming Healthed Webcast

Cardiovascular Risk and Fatty Liver Disease

Tuesday 11th November, 7pm - 9pm AEDT

Speaker

A/Prof William Kemp

Gastroenterologist and Hepatologist; Alfred Hospital Melbourne, Monash University School of Translational Medicine

We invite you to our next free webcast, where I will discuss cardiovascular risk and fatty liver disease. Earn up to 4 hours CPD. RACGP & ACRRM accredited.